デフォルト表紙
市場調査レポート
商品コード
1616420

ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)の世界市場規模:タイプ別、技術別、用途別、地域別、範囲および予測

Global Optical Coherence Tomography For Healthcare And Life Science Market Size By Type, By Technology (Time Domain OCT, Frequency Domain OCT ), By Application, By Geographic Scope And Forecast


出版日
ページ情報
英文 202 Pages
納期
2~3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)の世界市場規模:タイプ別、技術別、用途別、地域別、範囲および予測
出版日: 2024年10月30日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)の市場規模と予測

ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)市場規模は、2024年に14億8,000万米ドルと評価され、2024年から2031年にかけてCAGR 7.35%で成長し、2031年には28億4,000万米ドルに達すると予測されます。ヘルスケアやライフサイエンス業界におけるより複雑な機器の必要性の増加や、網膜の疾患に関する意識の高まりといった要因が、光コヒーレンストモグラフィ(OCT)市場の成長を促進しています。この調査レポートは、光干渉断層計(OCT)のヘルスケアおよびライフサイエンス向け世界市場を総合的に評価・分析しています。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)の世界市場定義

光コヒーレンストモグラフィは、高解像度の断面画像技術であり、現在も進化を続けています。OCTは、光を用いてミクロン単位の組織構造をその場でリアルタイムに画像化する技術です。光生検は、非侵襲的なイメージング技術であるOCTを用いて行われます。従来のイメージング技術が適切でない状況で使用されます。OCTは光ファイバーをベースにしており、内視鏡、カテーテル、手術用プローブ、腹腔鏡などの器具と併用して体内を画像化することができます。

定量的な情報を提供し、診断性能を向上させるために、偏光感応型OCT、ドップラーOCT、蛍光と組み合わせたOCTなど、いくつかの機能的OCT法が研究されています。目標は、皮膚科や歯科などの基本的な用途に使用できる、小型で低コスト、携帯可能なOCTシステムの製造を可能にすることです。

ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)の世界市場概要

OCTは、様々な病態の診断やモニタリングのための非侵襲的でラベルフリーの生体内イメージング法に対する需要が高まるにつれて普及しています。この需要は、中国やインドなどの新興諸国で特に高まっています。ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)市場の最新動向には、歯科、皮膚科などの分野で基本的な応用が可能な、低コスト、ポータブル、コンパクトなOCTシステムの開発に重点を置くプレーヤーが含まれています。

現在、装置の小型化と設計の改善が主な焦点となっており、マイクロ光コヒーレンストモグラフィの人気の高まりは、今後数年間で大きなチャンスとなる可能性があります。市場参入企業は"OCT in a chip "の開発に力を注いでおり、規制への対応や承認手続き次第では、今後数年で市場に登場する見込みです。マイクロ光コヒーレンストモグラフィは現在、世界の業界で最も注目されている市場動向の一つです。しかし、同市場では、有利な医療償還制度の欠如や限られた臨床データが大きな阻害要因となっています。

目次

第1章 ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)世界市場:イントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • 検証
  • 一次インタビュー
  • データソース一覧

第4章 ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)の世界市場展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析

第5章 ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)の世界市場:技術別

  • 概要
  • 時間領域オクト(tdoct)
  • 周波数領域オクト(fd-oct)
  • 空間エンコード周波数領域オクト

第6章 ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)の世界市場:タイプ別

  • 概要
  • カテーテルベースOCT装置
  • ドップラーオクト装置
  • ハンドヘルドOCT装置
  • 卓上型オクト装置

第7章 ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)の世界市場:用途別

  • 概要
  • 眼科
  • 心血管系
  • 腫瘍学
  • 皮膚科学
  • その他

第8章 ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)の世界市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第9章 ヘルスケアおよびライフサイエンス向け光コヒーレンストモグラフィ(OCT)の世界市場:競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な開発戦略

第10章 企業プロファイル

  • ABBOTT(OPTIMEDICA)
  • CANON
  • OPTOMEDICAL TECHNOLOGIES
  • SANTEC
  • ST JUDE MEDICAL
  • NINE POINT MEDICAL
  • CARL ZEISS MEDITEC
  • ALCON
  • THORLABS INC.
  • AGFA HEALTHCARE

第11章 主な発展

  • 製品の発売/開発
  • 合併と買収
  • 事業拡大
  • パートナーシップと提携

第12章 付録

  • 関連調査
目次
Product Code: 5731

Optical Coherence Tomography (OCT) For Healthcare And Life Science Market Size And Forecast

Optical Coherence Tomography (OCT) For Healthcare And Life Science Market size was valued at USD 1.48 Billion in 2024 and is projected to reach USD 2.84 Billion by 2031, growing at a CAGR of 7.35% from 2024 to 2031. Factors such as the increase in the necessity for more complex instruments in the healthcare and life science industries as well as the increase in the awareness concerning diseases of the retina are driving the market growth for Optical Coherence Tomography (OCT). The Global Optical Coherence Tomography (OCT) For Healthcare And Life Science Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Optical Coherence Tomography (OCT) For Healthcare And Life Science Market Definition

Optical coherence tomography is a high-resolution cross-sectional imaging technique that is still evolving. OCT is a technique for imaging tissue structure on a micron scale in situ and in real-time using light. An optical biopsy is performed using an OCT, which is a non-invasive imaging technique. It's used in situations where traditional imaging techniques aren't appropriate. OCT is based on fiber optics and can be used in conjunction with instruments such as endoscopes, catheters, surgical probes, and laparoscopes to image the body.

Several functional OCT methods are being investigated to provide quantitative information and improve diagnosis performance, including polarization-sensitive OCT, Doppler OCT, and OCT combined with fluorescence. The goal is to enable the production of compact, low-cost, and portable OCT systems for use in basic applications such as dermatology and dentistry.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Optical Coherence Tomography (OCT) For Healthcare And Life Science Market Overview

OCT is becoming more popular as the demand for non-invasive, label-free in vivo imaging methods for diagnosing and monitoring various pathologies grows. This demand is particularly high in developing countries like China and India. The latest Optical Coherence Tomography (OCT) For Healthcare And Life Science Market trends include players putting more emphasis on developing low-cost, portable, and compact OCT systems with basic applications in dentistry, dermatology, and other fields.

With miniaturization and improvements in device design currently being the main focus areas, the growing popularity of micro-optical coherence tomography could be a huge opportunity in the coming years. Market participants are focusing their efforts on developing "OCT in a chip," which is expected to hit the market in the next few years, depending on regulatory compliance and approval procedures. Micro-optical coherence tomography is currently one of the most popular market trends in the global industry. However, in the market, a lack of favorable medical reimbursement schemes, as well as limited clinical data, are major deterrents.

Global Optical Coherence Tomography (OCT) For Healthcare And Life Science Market: Segmentation Analysis

The Global Optical Coherence Tomography (OCT) For Healthcare And Life Science Market is Segmented on the basis of Technology, Type, Application, And Geography.

Optical Coherence Tomography (OCT) For Healthcare And Life Science Market, By Technology

  • Time Domain OCT (TDOCT)
  • Frequency Domain OCT (FD-OCT)
  • Spatial Encoded Frequency Domain OCT

Based on Technology, the market is bifurcated into Time Domain OCT (TDOCT), Frequency Domain OCT (FD-OCT), and Spatial Encoded Frequency Domain OCT. The most revenue was generated by the frequency domain optical coherence tomography (FD-OCT) segment. Frequency-domain OCT systems, also known as spectral-domain OCT, are primarily based on the measurement of the interference spectrum (SD-OCT). Interferometric signals are used as an imaging aid in the spectral domain OCT, which helps to increase imaging speed by up to 50 times. As a result, there will be more images per unit area, increasing market penetration in the forecast years.

Optical Coherence Tomography (OCT) For Healthcare And Life Science Market, By Type

  • Catheter-Based OCT Devices
  • Doppler OCT Devices
  • Handheld OCT Devices
  • Tabletop OCT Devices

Based on Type, the market is bifurcated into Catheter-Based OCT Devices, Doppler OCT Devices, Handheld OCT Devices, and Tabletop OCT Devices. Handheld OCT devices account for the majority of the market. Microelectromechanical systems (MEMS) and 3D imaging are combined in handheld OCTs to aid in the early detection of a variety of eye disorders. Diabetic retinopathy, macular degeneration, and glaucoma can all be detected using this method.

Optical Coherence Tomography (OCT) For Healthcare And Life Science Market, By Application

  • Ophthalmology
  • Cardiovascular
  • Oncology
  • Dermatology
  • Others

Based on Application, the market is bifurcated into Ophthalmology, Cardiovascular, Oncology, Dermatology, and Others. The most popular specialty is ophthalmology. Because of the rising incidences of choroidal and retinal disorders, ophthalmology is expected to grow rapidly in the future, leading to an increase in the use of optical coherence tomography devices by ophthalmologists for imaging and diagnosis. Furthermore, as the prevalence of cataracts and glaucoma rises, people will seek out early disease detection and better treatment options with OCT devices, boosting the market.

Optical Coherence Tomography (OCT) For Healthcare And Life Science Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, the Global Optical Coherence Tomography (OCT) For Healthcare And Life Science Market is classified into North America, Europe, Asia Pacific, and Rest of the world. NA dominates the market due to the rise in eye diseases. Moreover, during the forecast period, the emergence of major players will further boost the growth of the market in the region. The Market in Asia-Pacific is expected to grow significantly due to rising healthcare costs. Furthermore, the growing awareness of eye disorders is expected to drive the growth of the market in the region over the forecast period.

Key Players

  • The "Global Optical Coherence Tomography (OCT) for Healthcare & Life Science Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Abbott, Canon, OptoMedical Technologies, Santec, NinePoint Medical, Carl Zeiss Meditec, Alcon, Thorlabs, Agfa-Gevaert Group, etc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

  • November 2020 - A team of researchers from the Severance Hospital in the United States has developed a machine learning-based fractional flow reserve prediction technology that heavily relies on optical coherence tomography images and patient biometric data. This technology aids in the treatment of patients undergoing coronary intervention surgery and has the potential to become a major player in the intravascular optical coherence tomography OCT imaging systems market in the coming years.
  • December 2020 - RetinAI Medical has announced a partnership with Novartis Pharma, which will see RetinAI's artificial intelligence tools used to support a variety of ophthalmology and digital health projects. The agreement supports a multi-center clinical trial examining the effects of using Artificial Intelligence (AI) to analyze optical coherence tomography images.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) FOR HEALTHCARE AND LIFE SCIENCE MARKET

  • 1.1 OVERVIEW OF THE MARKET
  • 1.2 SCOPE OF REPORT
  • 1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 DATA MINING
  • 3.2 VALIDATION
  • 3.3 PRIMARY INTERVIEWS
  • 3.4 LIST OF DATA SOURCES

4 GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) FOR HEALTHCARE AND LIFE SCIENCE MARKET OUTLOOK

  • 4.1 OVERVIEW
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
    • 4.2.2 RESTRAINTS
    • 4.2.3 OPPORTUNITIES
  • 4.3 PORTERS FIVE FORCE MODEL
  • 4.4 VALUE CHAIN ANALYSIS

5 GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) FOR HEALTHCARE AND LIFE SCIENCE MARKET, BY TECHNOLOGY

  • 5.1 OVERVIEW
  • 5.2 TIME DOMAIN OCT (TDOCT)
  • 5.3 FREQUENCY DOMAIN OCT (FD-OCT)
  • 5.4 SPATIAL ENCODED FREQUENCY DOMAIN OCT

6 GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) FOR HEALTHCARE AND LIFE SCIENCE MARKET, BY TYPE

  • 6.1 OVERVIEW
  • 6.2 CATHETER-BASED OCT DEVICES
  • 6.3 DOPPLER OCT DEVICES
  • 6.4 HANDHELD OCT DEVICES
  • 6.5 TABLETOP OCT DEVICES

7 GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) FOR HEALTHCARE AND LIFE SCIENCE MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 OPHTHALMOLOGY
  • 7.3 CARDIOVASCULAR
  • 7.4 ONCOLOGY
  • 7.5 DERMATOLOGY
  • 7.6 OTHERS

8 GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) FOR HEALTHCARE AND LIFE SCIENCE MARKET, BY GEOGRAPHY

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA
    • 8.2.1 U.S.
    • 8.2.2 CANADA
    • 8.2.3 MEXICO
  • 8.3 EUROPE
    • 8.3.1 GERMANY
    • 8.3.2 U.K.
    • 8.3.3 FRANCE
    • 8.3.4 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 CHINA
    • 8.4.2 JAPAN
    • 8.4.3 INDIA
    • 8.4.4 REST OF ASIA PACIFIC
  • 8.5 REST OF THE WORLD
    • 8.5.1 LATIN AMERICA
    • 8.5.2 MIDDLE EAST AND AFRICA

9 GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) FOR HEALTHCARE AND LIFE SCIENCE MARKET COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 COMPANY MARKET RANKING
  • 9.3 KEY DEVELOPMENT STRATEGIES

10 COMPANY PROFILES

  • 10.1 ABBOTT (OPTIMEDICA)
    • 10.1.1 OVERVIEW
    • 10.1.2 FINANCIAL PERFORMANCE
    • 10.1.3 PRODUCT OUTLOOK
    • 10.1.4 KEY DEVELOPMENTS
  • 10.2 CANON
    • 10.2.1 OVERVIEW
    • 10.2.2 FINANCIAL PERFORMANCE
    • 10.2.3 PRODUCT OUTLOOK
    • 10.2.4 KEY DEVELOPMENTS
  • 10.3 OPTOMEDICAL TECHNOLOGIES
    • 10.3.1 OVERVIEW
    • 10.3.2 FINANCIAL PERFORMANCE
    • 10.3.3 PRODUCT OUTLOOK
    • 10.3.4 KEY DEVELOPMENTS
  • 10.4 SANTEC
    • 10.4.1 OVERVIEW
    • 10.4.2 FINANCIAL PERFORMANCE
    • 10.4.3 PRODUCT OUTLOOK
    • 10.4.4 KEY DEVELOPMENTS
  • 10.5 ST JUDE MEDICAL
    • 10.5.1 OVERVIEW
    • 10.5.2 FINANCIAL PERFORMANCE
    • 10.5.3 PRODUCT OUTLOOK
    • 10.5.4 KEY DEVELOPMENTS
  • 10.6 NINE POINT MEDICAL
    • 10.6.1 OVERVIEW
    • 10.6.2 FINANCIAL PERFORMANCE
    • 10.6.3 PRODUCT OUTLOOK
    • 10.6.4 KEY DEVELOPMENTS
  • 10.7 CARL ZEISS MEDITEC
  • 10.8 ALCON
    • 10.8.1 OVERVIEW
    • 10.8.2 FINANCIAL PERFORMANCE
    • 10.8.3 PRODUCT OUTLOOK
    • 10.8.4 KEY DEVELOPMENTS
  • 10.9 THORLABS INC.
    • 10.9.1 OVERVIEW
    • 10.9.2 FINANCIAL PERFORMANCE
    • 10.9.3 PRODUCT OUTLOOK
    • 10.9.4 KEY DEVELOPMENTS
  • 10.10 AGFA HEALTHCARE
    • 10.10.1 OVERVIEW
    • 10.10.2 FINANCIAL PERFORMANCE
    • 10.10.3 PRODUCT OUTLOOK
    • 10.10.4 KEY DEVELOPMENTS

11 KEY DEVELOPMENTS

  • 11.1 PRODUCT LAUNCHES/DEVELOPMENTS
  • 11.2 MERGERS AND ACQUISITIONS
  • 11.3 BUSINESS EXPANSIONS
  • 11.4 PARTNERSHIPS AND COLLABORATIONS

12 APPENDIX

  • 12.1 RELATED RESEARCH